BIONET Corp. (TPEX:1784)
Taiwan · Delayed Price · Currency is TWD 103.50
+3.70 (3.71%)
Oct 31, 2025, 2:32 PM CST
BIONET Revenue
BIONET had revenue of 304.40M TWD in the quarter ending June 30, 2025, with 3.96% growth. This brings the company's revenue in the last twelve months to 1.23B, up 5.58% year-over-year. In the year 2024, BIONET had annual revenue of 1.22B with 8.40% growth.
Revenue (ttm)
1.23B
Revenue Growth
+5.58%
P/S Ratio
4.48
Revenue / Employee
n/a
Employees
n/a
Market Cap
5.50B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.22B | 94.73M | 8.40% |
| Dec 31, 2023 | 1.13B | 146.93M | 14.99% |
| Dec 31, 2022 | 980.38M | 58.96M | 6.40% |
| Dec 31, 2021 | 921.42M | 114.85M | 14.24% |
| Dec 31, 2020 | 806.58M | 31.02M | 4.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bora Pharmaceuticals Co., LTD. | 21.32B |
| Lotus Pharmaceutical | 19.12B |
| PharmaEssentia | 12.63B |
| Pegavision | 6.90B |
| Center Laboratories | 1.60B |
| Oneness Biotech | 112.57M |
| Polaris Group | 64.02M |
| Caliway Biopharmaceuticals | 44.83M |